Back to results
CompletedPhase 2

Intranasal Insulin in Parkinson's Disease

NCT04251585

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

HealthPartners Neuroscience Center

Saint Paul, Minnesota, United States

View on ClinicalTrials.gov
Intranasal Insulin in Parkinson's Disease — TrialFind